Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
deals
2
×
life sciences
national blog main
national top stories
achromatopsia
beta-thalassemia
bill cassidy
biopharma
biotech
bluebird bio
boston
clinical trials
dna
duchenne
europe blog main
europe top stories
fda
gene therapy
harvard pilgrim health care
hemophilia
johnson & johnson
licensing
luxturna
m&a
mark warner
mathai mammen
medicaid
meiragtx
muscular dystrophy
new york
new york blog main
new york top stories
novartis
patient affordability value and efficiency act
roche
sarepta therapeutics
spark therapeutics
spinal muscular atrophy
What
deal
2
×
gene
2
×
therapy
age
approval
betting
bigger
biggest
billion
biopharma
come
duchenne
emerging
fda
gave
historic
j
johnson
medicine
meiragtx
morning
past
puts
recently
rna
roche
sarepta
second
signal
signals
swiss
therapeutics
won
years
Language
unset
Current search:
deals
×
deal
×
gene
×
@xconomy.com
4 years ago
Roche Puts Up Historic $1.15B for Sarepta Duchenne Gene Therapy Deal
@xconomy.com
5 years ago
With $100M MeiraGTx Deal, J&J Signals Bigger Move Into Gene Therapy
